Medical News

RSS

Study examines long-term effect of TBI on women's reproductive health

After a brain injury, women often ask how the injury will affect their fertility, pregnancy and postpartum health. Now a new study provides some much-needed answers. Published in the June issue of the Journal of Women's Health, the study is the most comprehensive investigation to date of women's health issues after traumatic brain injury.

1 Jul 2010

Behavioral intervention program can reduce incidence of HIV, STIs among female sex workers: Researchers

A team of researchers from the University of California San Diego and Mexico has found that even a modest behavioral intervention program averaging just 35 minutes can measurably reduce the incidence of HIV and sexually transmitted infections among female sex workers in the U.S.-Mexico border region - and that the program succeeds at comparatively little expense.

1 Jul 2010

CED report warns that health care reform will not succeed without cost reforms

The health-care delivery system and payment structure need significant reforms, or the health care reform law passed by Congress will prove to be an "empty promise." That is the conclusion of a new report, Health Care in California and National Health Reform, from the business-led Committee for Economic Development.

1 Jul 2010

Evotec commences EVT 101 proof-of-concept Phase II study in treatment-resistant depression

Evotec AG today announced the start of the proof-of-concept Phase II study in treatment-resistant depression with its NR2B subtype selective NMDA receptor antagonist EVT 101. This clinical development is part of an alliance between Evotec and Roche.

1 Jul 2010

CBO Director: Potential health law savings not enough to reduce long-term deficits

Congressional Budget Office findings that for the first time take into consideration "the new health care law, heralded by President Obama and Democrats for reducing deficits in the long run" were presented today before the president's bipartisan fiscal commission. Among the CBO conclusions is that savings that result from the overhaul "aren't enough to turn deficits around."

1 Jul 2010

Ecolab launches Virasept to treat Clostridium difficile spores

Ecolab Inc. today announced the launch of Virasept, Ecolab's first ready-to-use (no mixing required) hard surface disinfectant approved by the U.S. Environmental Protection Agency to be effective against Clostridium difficile spores.

1 Jul 2010

Lawmakers urge swifter launch of home health care demo

"The so-called Independence at Home (IAH) program, included as part of the Democrats' new health reform law, is scheduled to take effect no later than Jan. 1, 2012, but Sen. Ron Wyden (D-Ore.) and Rep. Edward Markey (D-Mass.) warn that waiting that long would threaten the health of one of the country's most vulnerable populations," The Hill reports.

1 Jul 2010

Pre-clinical data of BiTE antibody technology published in PNAS

Micromet, Inc., today announced the publication of pre-clinical data in the Proceedings of the National Academy of Sciences, demonstrating the potency of new product candidates based on the Company's proprietary BiTE antibody technology. BiTE antibodies are a new class of agents designed to harness a patient's T cells to kill cancer cells.

1 Jul 2010

Sleep enhances ability to remember to do something in future

When it comes to executing items on tomorrow's to-do list, it's best to think it over, then "sleep on it," say psychologists at Washington University in St. Louis.

1 Jul 2010

CBio achieves recruitment milestone in XToll clinical trial

Australian drug development company CBio Limited today announced the achievement of a recruitment milestone in its clinical trial of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis.

1 Jul 2010

BIDMC physician-scientist receives Young Investigator Award to research on prostate cancer

Akash Patnaik, MD, PhD, a physician-scientist in the Hematology/Oncology Divison at Beth Israel Deaconess Medical Center and Instructor of Medicine at Harvard Medical School has received a Young Investigator Award from The Prostate Cancer Foundation. The three-year $225,000 award, one of 21 made to young scientists from across the U.S. and Canada, is designed to encourage the most innovative minds in cancer research to focus their careers on prostate cancer.

1 Jul 2010

Biospherics acquires worldwide patent rights to Dtagatose from UKRF

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University of Kentucky Research Foundation (UKRF).

1 Jul 2010

World Bank, WHO, UNAIDS report offers comprehensive look at HIV/AIDS in Middle East, N. Africa

The World Bank, WHO and UNAIDS on Monday released a joint report that pulls together data characterizing the HIV/AIDS epidemic from 23 countries in the Middle East and North Africa region, IRIN reports (6/30).

1 Jul 2010

AAMC report urges U.S. teaching hospitals to deal with conflicts of interest in clinical care

A new report by the AAMC urges U.S. teaching hospitals to establish policies that manage financial relationships between physicians and industry so that they do not influence patient care. "In the Interest of Patients: Recommendations for Physician Financial Relationships and Clinical Decision Making" provides guidance on how academic medical centers can identify, evaluate, and disclose conflicts of interest in clinical care.

1 Jul 2010

Judge rules for Merck in state Vioxx lawsuit over Medicaid payments

A federal judge ruled in favor of Merck & Co. Tuesday in a lawsuit brought by Louisiana trying to recoup what it paid when Medicaid patients used the company's withdrawn painkiller Vioxx, The Associated Press reports. James R. Dugan II, "the lead attorney representing Louisiana, said his team would be meeting with state officials later this week to discuss appellate possibilities.

1 Jul 2010

GeoVax Labs postpones proposed public offering

GeoVax Labs, Inc., a biotechnology company dedicated to developing vaccines that prevent and fight human immunodeficiency virus (HIV), today announced that it has decided to postpone its proposed public offering of units, each consisting of a share of common stock and a warrant to purchase another share.

1 Jul 2010

XOMA reaches enrollment goal of 325 patients for Phase 2b clinical trial of XOMA 052

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.

1 Jul 2010

Research findings open new ways to enhance memory function and treat catastrophic brain diseases

For the first time, scientists have linked a brain compound called kynurenic acid to cognition, possibly opening doors for new ways to enhance memory function and treat catastrophic brain diseases, according to a new study from the University of Maryland School of Medicine. When researchers decreased the levels of kynurenic acid in the brains of mice, their cognition was shown to improve markedly, according to the study, which was published in the July issue of the journal Neuropsychopharmacology.

1 Jul 2010

Gen-Probe's APTIMA Trichomonas assay receives European CE mark

Gen-Probe Incorporated announced today that it has received a European CE mark for its APTIMA® assay for Trichomonas vaginalis, a common parasitic sexually transmitted disease.

1 Jul 2010

Wellpoint warns 470,000 insurance applicants about website security breach

"WellPoint Inc. has warned some 470,000 people who applied for its health insurance that a website security glitch may have exposed their Social Security numbers and other sensitive data to the public." WellPoint quickly fixed the problem after being notified by a consumer who noticed it. The glitch "was introduced in October by a contractor who upgraded the site," according to a company spokesman. According to WellPoint officials, the "security glitch was exploited to access information on 940 insurance applications" and "unauthorized viewers accessed spreadsheets that 'in rare cases' contained Social Security numbers" (Finkle, 6/29).

1 Jul 2010

Medical News

Study examines long-term effect of TBI on women's reproductive health

Behavioral intervention program can reduce incidence of HIV, STIs among female sex workers: Researchers

CED report warns that health care reform will not succeed without cost reforms

Evotec commences EVT 101 proof-of-concept Phase II study in treatment-resistant depression

CBO Director: Potential health law savings not enough to reduce long-term deficits

Ecolab launches Virasept to treat Clostridium difficile spores

Lawmakers urge swifter launch of home health care demo

Pre-clinical data of BiTE antibody technology published in PNAS

Sleep enhances ability to remember to do something in future

CBio achieves recruitment milestone in XToll clinical trial

BIDMC physician-scientist receives Young Investigator Award to research on prostate cancer

Biospherics acquires worldwide patent rights to Dtagatose from UKRF

World Bank, WHO, UNAIDS report offers comprehensive look at HIV/AIDS in Middle East, N. Africa

AAMC report urges U.S. teaching hospitals to deal with conflicts of interest in clinical care

Judge rules for Merck in state Vioxx lawsuit over Medicaid payments

GeoVax Labs postpones proposed public offering

XOMA reaches enrollment goal of 325 patients for Phase 2b clinical trial of XOMA 052

Research findings open new ways to enhance memory function and treat catastrophic brain diseases

Gen-Probe's APTIMA Trichomonas assay receives European CE mark

Wellpoint warns 470,000 insurance applicants about website security breach

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News